Extracellular Domains of CARs Reprogram T-Cell Metabolism without Antigen Stimulation
Bulk RNA sequencing of CARs in FMC63-based anti-CD19, Leu16 anti-CD20, rituximab anti-CD20, RFR-LCDR anti-CD20, rituximab.AA anti-CD20, RFR-LCDR.AA anti-CD20, and 14g2a-based anti-GD2 CAR-T cells without antigen stimulation